{"_path":"/studies/51","_dir":"studies","_draft":false,"_partial":false,"_locale":"","id":"51","record_id":"51","name_study":"Beobachtung von Markern in der Bildgebung und im Blut in der  Ketamintherapie von therapieresistenten Depressionen (NeuroMarKet)","dzpg_site":"Jena/Magdeburg/Halle","description_study":"Primäres Ziel:  Identifizierung und Korrelation möglicher Blut- (BDNF, mTOR, Acet-Tub, Blutproteom,  Exosom, Metaboliten des Tryptophan-Pfads  (Kynureninsäure, Tryptophan, Kynurenin, 3-Hydroxykynurenin und Chinolinsäure)) und Gehirnbiomarker (elektrophysiologische Signaturen, Signaturen der fMRT Bildgebung,  Glutamatkonzentration im Gehirn (MRS)), sowie weiterer individueller Charakteristika bei Patient:innen, die von einer Ketamintherapie bezüglich ihrer Depression profitieren.    Sekundäres Ziel:  Identifizierung und Korrelation von physiologischen (Bewegungs-)  Parametern, Genexpressions-  und Methylierungsmustern, weiteren Biomaterialien (Darmflora) und Ketaminmetabolit-Konzentrationen sowie von subjektivem Erfahren von Nebenwirkungen (qualitative Analyse von mikrophänomolgoischen Gesprächen) bei Patient:innen, die von einer Ketamintherapie bezüglich ihrer Depression profitieren.","title_pi":"Prof. Dr.","given_name_pi":"Martin","family_name_pi":"Walter","further_pi":"Prof. Dr. Nils Opel (Stellvertreter des  Studienleiters)","contact_mail":"martin.walter@med.uni-jena.de","contact_phone":"36419390101","study_status":"Ongoing (II): Recruitment and data collection ongoing","type_intervention":["Interventional"],"type_specification_non_int":[],"type_specification_int":["Single group"],"setting":"Multicentric","n_sites":"2","setting_country":"Multi","n_countries":"1","which_countries":"Germany","participants":["Patients with specific diseases"],"specific_diseases":["Mental, behavioural or neurodevelopmental disorders (06)"],"mental_disorders":["Mood disorders"],"somatic_disorders":[],"recruited":["Hospital","Outpatient"],"n_participants_target":"100","n_participants_obtained":"20","start_recruitment":"2023","min_age":"18","data_sources":["Biological samples","Imaging data","Medical records","Interview","Questionnaire","Omics technology","Smartphone or wearable based data"],"data_sharing":"Yes, there is a plan to make data available","data_sharing_additional":"Data sharing to third parties is allowed with the following comment: \"Vor einer Weitergabe an Forscher außerhalb meiner behandelnden Einrichtung erfolgt zudem eine weitere Ersetzung des internen Kennzeichens durch eine neue Zeichenkombination.\"","planned_follow_ups":"No","consent_recontact":"Yes","further_components":"No","comments":"Re-contacting the patients is only allowed for UKJ employees.","pi_full":"Prof. Dr. Martin Walter","_id":"content:studies:51.json","_type":"json","title":"51","_source":"content","_file":"studies/51.json","_stem":"studies/51","_extension":"json"}